argenx
π§πͺBelgium
- Country
- π§πͺBelgium
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- $31.2B
- Website
- https://www.argenx.com/
A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- argenx
- Target Recruit Count
- 11
- Registration Number
- NCT02759250
- Locations
- π§πͺ
UZG - Universitair Ziekenhuis Gent, Gent, Belgium
A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- argenx
- Target Recruit Count
- 24
- Registration Number
- NCT02055066
- Locations
- π§πͺ
Institut Jules Bordet, Brussels, Belgium
π§πͺUniversitair Zieckenhuis Antwerpen, Antwerp, Belgium
Β© Copyright 2024. All Rights Reserved by MedPath